Titelia

Holdings of Kynam Capital Management, LP

30 declared positions · as of Mar 31, 2026

Original filing · Ten largest lines: 76.4 % of the equity sleeve

Sector breakdown

  • Unattributed 100.0 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • US 96.3 %
  • KY 3.2 %
  • GB 0.5 %

Shares computed on the equity sleeve.

RankCountryLinesValueShare
1US271.4B $96.31 %
2KY248.3M $3.24 %
3GB16.8M $0.46 %

Positions

RankCompanySharesValueWeight
1Syndax Pharmaceuticals Inc 8,050,959188.1M $
2Celldex Therapeutics Inc 5,840,567185.3M $
3Vaxcyte Inc 2,922,335169.8M $
4Cogent Biosciences Inc 4,037,331155.4M $
5Vera Therapeutics Inc 3,398,224136.7M $
6Beam Therapeutics Inc 3,682,18587.7M $
7CytomX Therapeutics Inc 15,013,09370.6M $
8BioCryst Pharmaceuticals Inc 5,680,79554.1M $
9Travere Therapeutics Inc 1,569,01846.6M $
10Viridian Therapeutics Inc 2,341,65245.8M $
11Cullinan Therapeutics Inc 3,114,13244.3M $
12KalVista Pharmaceuticals Inc 1,820,95436.7M $
13Apellis Pharmaceuticals Inc 825,00033.2M $
14LEGEND BIOTECH CORP 1,576,29528.5M $
15MBX Biosciences Inc 934,79927.9M $
16Immunocore Holdings PLC 884,93726.7M $
17Sutro Biopharma Inc 872,55821.7M $
18Burning Rock Biotech Ltd 1,227,55519.8M $
19Soleno Therapeutics Inc 560,00018.7M $
20Nurix Therapeutics Inc 1,194,75718.5M $
21Evommune Inc 625,49614.4M $
22Relay Therapeutics Inc 1,424,25914.2M $
23Geron Corp 6,836,31810.2M $
24Design Therapeutics Inc 784,6068.3M $
25Climb Bio Inc 1,003,3416.9M $
26Amarin Corp PLC 472,3826.8M $
27Prelude Therapeutics Inc 1,592,5515.4M $
28Caribou Biosciences Inc 2,503,3024.8M $
29Alector Inc 2,000,0004.3M $
30Candel Therapeutics Inc 200,000980K $